Skip to main content
Alzheimer's & Dementia logoLink to Alzheimer's & Dementia
. 2026 Jul 20;22(7):e71323. doi: 10.1002/alz.71323

The effect of psychosocial and healthcare interventions on reducing hospitalization in people with dementia: an umbrella review

Connie Howard 1, Alba Fernández‐Sanlés 1, Nawal Abukar 1, Daniel Davis 2, Claire Goodman 3, Sanjiv Gupta 1, Melanie Handley 3, Naaheed Mukadam 1,4, Carol Riddington 1, Kate Walters 5,6, Gill Livingston 1,4, Andrew Sommerlad 1,4,
PMCID: PMC13383009  PMID: 42473950

Abstract

People with dementia are at increased risk of hospitalization compared to individuals without dementia, yet the efficacy of psychosocial and healthcare interventions in reducing hospitalization is unclear. We conducted an umbrella review examining the effects of psychosocial and healthcare interventions compared to controls on reducing hospitalization in people with dementia. We included 25 systematic reviews comprising 77 unique studies totaling 1,483,077 participants. There was high‐certainty evidence that case management and exercise programs had no effect on reducing hospitalization, low‐certainty evidence that advance care planning reduced hospital admissions, and moderate‐certainty evidence that clinical pharmacists in multidisciplinary teams (MDTs) reduced medication‐related hospital re‐admissions. The evidence for psychosocial and healthcare interventions in reducing hospitalization in dementia is insufficient to make strong positive recommendations, but there are indications that advance care planning and clinical pharmacists in MDTs may be beneficial. High‐quality randomized controlled trials are required to establish more confident clinical recommendations.

Keywords: dementia, emergency department, healthcare use, hospitalization, psychosocial interventions

Highlights

  • Umbrella review of 25 reviews comprising 77 unique papers and 1,483,077 participants.

  • Interventions previously thought to be effective, such as case management programs and encouraging exercise, have no effect on hospitalization rates or length of stay.

  • There is moderate certainty evidence that including clinical pharmacists in multi‐disciplinary teams reduces medication‐related hospital admissions of people with dementia.

  • There is low‐certainty evidence that advance care planning reduces hospitalization.

  • There is a lack of evidence for other interventions to accurately gauge their effectiveness.

1. INTRODUCTION

The number of people living with dementia (PwD) globally is expected to increase from 57 million in 2019 to 152 million by 2050. 1 As PwD have a 42% increased risk of admission to acute hospital care compared with those without dementia, even after adjusting for physical comorbidities, there will be substantially increased hospital use. 2 In the United Kingdom (UK), PwD occupy one in six hospital beds, with £2.8 billion annual costs due to hospital inpatient admissions, and it is expected that by 2040, one quarter of hospital inpatients will have dementia. 3 Once admitted, PwD stay in acute hospitals up to seven times longer than age‐matched patients 4 and are at a 7% to 35% increased risk of readmission. 5 , 6 Admissions to acute hospitals can also have a significant negative impact on the health of PwD, including increased mortality 7 , 8 , 9 , 10 and frailty, 9 , 11 more inpatient complications, 12 , 13 and further cognitive and functional decline 8 , 9 , 13 , 14 , 15 , 16 with only 42% of PwD recovering to their pre‐hospitalization level of function. 17 Acute hospitals are fast‐paced environments that are usually not specifically designed to care for PwD, 9 , 18 , 19 with staff who often report feeling inadequately prepared and supported to look after PwD. 3 , 20

While some hospital admissions are essential and appropriate, 20% to 49% of hospitalizations of PwD are potentially preventable, 4 , 21 , 22 often as defined as admissions for ambulatory care‐sensitive conditions (ACSCs). ACSCs are health concerns such as urinary tract infections or pain that could theoretically have been treated on an outpatient basis through early intervention, preventing admission, 23 and these admission rates are 78% higher in people with dementia. 24 It is therefore crucial to consider how to reduce these admissions. Psychosocial and healthcare interventions may affect hospitalization risk by improving the person with dementia's or their family carer's ability to manage self‐care and medication regimens, developing coping mechanisms and the ability to seek appropriate early health‐seeking behaviors, improving neuropsychiatric symptoms, or other mechanisms. However, current evidence examining the effectiveness of psychosocial and healthcare interventions on reducing hospitalization in PwD is spread across different intervention types, with unclear efficacy. 25 Given the breadth and heterogeneity of interventions and outcome measures in this field, an updated systematic review of primary studies would risk inappropriate statistical pooling and limited comparability. We therefore chose an umbrella review, 26 to assess the consistency, strength, and gaps in the evidence base across intervention domains by synthesizing findings from existing systematic reviews and meta‐analyses.

Therefore, our aim was to conduct an umbrella review to synthesize the evidence on the efficacy and quality of psychosocial and healthcare interventions aimed at reducing hospitalization rates in PwD.

2. METHODS

We registered our umbrella review in PROSPERO and report our umbrella review according to Preferred Reporting Items for Overviews of Reviews (PRIOR) guidelines 27 (Table S1). We systematically searched the literature for published systematic reviews and meta‐analyses that examined the association between psychosocial and healthcare interventions and hospitalization (used as an overarching term encompassing hospital admissions and readmissions, length of stay [LoS] or delayed discharge, and emergency department [ED] visits) in PwD.

2.1. Information sources/search strategy

We searched systematically across four electronic databases from inception – MEDLINE, Embase, Cochrane, and CINAHL – in November 2024, with no language or date restrictions. Searches were re‐run on September 15, 2025, to ensure recent reviews were included. Keywords and Medical Subject Headings terms such as “hospitalization,” “emergency room visits,” and “dementia” were combined with Boolean operators to identify relevant systematic reviews and meta‐analyses. See Table S2 for the complete search strategy.

2.2. Selection process

Duplicates were removed using Covidence software. Two reviewers (C.H. and N.A.) independently screened titles and abstracts, followed by full‐text articles according to the predefined eligibility criteria, with detailed reasons for exclusion given in Table S3. At each stage, disagreements were discussed with G.L. and A.S. to reach a consensus. Inter‐rater reliability was assessed using Cohen's kappa, with values >0.81 considered almost perfect agreement, 0.61 to 0.80 substantial, 0.41 to 0.60 fair, and <0.40 no/slight agreement. 28

2.3. Eligibility criteria

Eligibility criteria were established using the Population, Intervention, Comparator, Outcome, Study type (PICOS) framework. Systematic reviews were eligible for inclusion if they included (1) PwD (population), (2) any psychological/social support/healthcare delivery interventions (intervention), (3) a suitable control group (control), and (4) a measure of hospitalization (outcome) and (5) were systematic (study type), defined as studies seeking to “collate all empirical evidence that fits pre‐specific eligibility criteria to answer a specific research question” using explicit, predefined methods to minimize bias. 29 Eligible study designs included randomized controlled trials (RCTs), non‐randomized studies of interventions (NRSIs), observational studies with intervention analysis, quasi‐experimental studies, and mixed‐method studies.

Systematic reviews were excluded if they focused on mild cognitive impairment (MCI) or delirium or if they analyzed the effects of pharmacological interventions on hospitalization. Studies were not eligible if they did not examine an intervention compared to a control. Therefore, qualitative studies, cross‐sectional studies, editorials, letters, and abstracts were also excluded. 26

2.4. Data extraction process

We created a custom document to extract the following data: author, publication year, location, methods (total relevant studies, number of RCTs, and observational studies), population (total relevant sample size, inclusion and exclusion criteria, mean age, and dementia severity information), intervention (intervention type, control group, setting, target, and length), results for each outcome, and quality assessments. One reviewer (C.H.) independently extracted data from each review according to our custom template, and a second reviewer (N.A.) checked for any discrepancies. To visualize overlap in primary studies between reviews, two reviewers (C.H. and N.A.) created a citation matrix (Figure S1), which was structured according to the interventions used in each primary study.

Where a primary study intervention was categorized differently between reviews, one reviewer (C.H.) examined the primary study to determine the study description and consulted with N.A., A.F.‐S., G.L., and A.S. to determine the accurate intervention label and adjusted the matrix accordingly (changes presented in Figure S1). Similarly, where individual study sample sizes were reported differently across reviews, one reviewer (C.H.) assessed the primary study to determine its true sample size. These verified sample sizes were then used to calculate the umbrella review's total sample size. The corresponding authors of systematic reviews were contacted 30 , 31 for clarification if they used unpublished data that did not correspond to the primary study.

2.5. Risk of bias assessment

Risk of bias was assessed using A Measurement Tool to Assess Systematic Reviews (AMSTAR II tool), 32 which was designed to assess RCTs and NRSIs. Critical domains in the assessment include the pre‐registration of review methods, comprehensive search strategies, justification of excluded studies, a satisfactory analysis of the risk of bias and publication bias, and the use of appropriate statistical combination methods. One reviewer (C.H.) independently rated all reviews according to these criteria and consulted A.S. and G.L. when unsure. See Table S4 for full AMSTAR II ratings.

2.6. Synthesis methods

We present our findings in a narrative synthesis. Due to study heterogeneity and a subsequent lack of meta‐analyses in many systematic reviews, we could not conduct meta‐analyses.

2.7. Certainty assessment

The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool 33 was used to assess the certainty of evidence. One reviewer (C.H.) assessed all included systematic reviews utilizing this framework, with a second reviewer (A.F.‐S.) independently assessing a random 10% in full to check for consistency. After this, the research team (C.H., A.F.‐S., G.L., and A.S.) discussed the GRADE ratings of all interventions and resolved any uncertainty by coming to a consensus and through rechecking data if necessary.

According to this approach, all observational studies began as low‐quality evidence, and RCTs began as high‐quality evidence. 34 Five criteria concern the downgrading of evidence: risk of bias, inconsistency, indirectness, imprecision, and publication bias, and three criteria gave the opportunity to upgrade the evidence: magnitude of effect, dose–response gradient, and plausible confounders. As some reviews included multiple interventions, with different effect estimates per intervention, the GRADE tool was applied to each intervention in each review so the ratings could make recommendations by intervention type. 35 According to these criteria, each intervention within each review was then categorized as having either “high,” “moderate,” “low,” or “critically low” certainty of evidence. When a study was reported across multiple reviews with different GRADE ratings, we included the study in both categories. We had a priori decided to prioritize higher‐quality review evidence over lower‐quality evidence in our synthesis of the evidence. Full GRADE ratings are provided in Table S5.

2.8. Public and patient involvement (PPI)

PPI members with experience caring for family members with dementia were involved in the umbrella review from its inception. Quarterly meetings were held with five members to discuss the review and its progress. PPI members assisted in creating a comprehensive search strategy, introducing lived experience to the interpretation of findings and identifying crucial areas for future research. Two members (C.R., S.G.) were involved as co‐authors of the article.

3. RESULTS

The initial search yielded 1828 studies, with 136 additional articles found in September 2025 (see Figure 1 for flow of studies). After deduplication, 1454 studies were eligible for screening. Following title and abstract screenings (n = 1454) and full text review (n = 53), 25 reviews were selected for data extraction. Inter‐rater agreement was substantial at the title and abstract screening stage (κ = 0.72) and at full‐text screening (κ = 0.80).

FIGURE 1.

FIGURE 1

Preferred reporting items for systematic reviews and meta‐analyses (PRISMA) global education and career consultants diagram.

Seventy‐seven unique studies with 1,483,077 participants, of whom 977,946 came from a single scoping review (RCTs = 47, NRSIs = 30) were included. Twenty‐two studies (28.6%) appeared in multiple reviews (Figure S1 for citation matrix showing overlap). Most studies were conducted in Europe (n = 38), followed by North America (n = 29), Australia (n = 5), East Asia (n = 4), and Southeast Asia (n = 1).

Twelve of 25 reviews (48%) assessed multiple intervention types. There was a range of intervention types, and we grouped interventions into broad categories to allow for efficient synthesis of findings. Most of the reviews examined the effects of case management (n = 15) on hospitalization of PwD, followed by multidisciplinary team (MDT) management (n = 9), physical activity interventions (n = 4), education/training programs (n = 4), type of hospital setting (n = 3), group activities (n = 3), post‐operative/discharge interventions (n = 2), palliative care (n = 2), counseling (n = 2), volunteering (n = 2), carer interventions (n = 1), and advance care planning (n = 1). Studies and the definitions of interventions they included are summarized in Table 1. According to AMSTAR II criteria (Table S4), three reviews were high quality, 19 , 30 , 36 eight were moderate quality, 31 , 37 , 38 , 39 , 40 , 41 , 42 , 43 four were low quality, 25 , 44 , 45 , 46 and 10 were critically low quality. 5 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 Issues leading to risk of bias and downgrading of quality mainly related to study protocols not being pre‐specified, search strategies that were insufficiently comprehensive, and inadequate methods for assessing risk of bias.

TABLE 1.

Descriptive table of systematic reviews including the types of studies reviewed, setting and outcome.

Review ID Location No. relevant studies (no. of RCTs) No. relevant participants Intervention type Control group Intervention setting Intervention target Outcome measured
Case management
Pimouguet (2010) 47 North America 3 (3) 659 Interaction between case manager and patient–caregiver dyads providing support, information, continuity, and advocacy for community services, financial and legal matters, and disease evolution. Usual care Community PwD or PwD–carer dyad
  • Hospital admission

  • LoS

  • ED visit

Tam‐Tham (2012) 31 North America 3 (3) 509 At least one healthcare professional including at least one component of assessment and planning, education, emotional support, service facilitation, or legal/financial advice Usual care Community PwD or PwD–carer dyad
  • Hospital admission

  • ED visit

Frost (2020) 49 North America and Southeast Asia 3 (1) 3665 Post‐diagnostic care from a primary care provider, including but not limited to structured needs assessments, caregiver support, referrals, and psychoeducation Usual care Community PwD or PwD–carer dyad
  • Hospital admission

  • Readmission

  • LoS

  • ED visit

Phelan (2015) 50 North America and Europe 8 (8) 2321 Case management/care coordination and multidisciplinary assessment and management (including exercise, safety, and carer support groups) Not specific Community PwD–carer dyad
  • Hospital admission

  • LoS

  • ED visits

Quinn (2020) 37 North America 1 (1) 780 Telephone‐based collaborative dementia care providing education, support, and care coordination Usual care Community PwD
  • Hospital admission

  • ED visits

Khanassov (2014) 46 East Asia 2 (2) 180 Structured needs assessments, care plans, education and support programs, and finance skills Usual care Community PwD or PwD– carer dyad
  • Hospital admission

Lee (2020) 25 North America and Europe 8 (7) 2666 Care coordination providing support, counseling information, follow‐up meetings, telehealth education programs, etc. Usual care Community PwD or PwD–carer dyad
  • Hospital admission

Reilly (2016) 30 North America and Europe 5 (5) 905 Any intervention in the community focused on planning and coordinating the needs of the PwD Usual care Community PwD or PwD–carer dyad
  • Hospital admission

  • LoS

  • ED visits

Demanes (2022) 52 North America 3 (3) 1411 Care coordinators providing telephone‐based education, linkage to services, skill building, informal counseling Usual care Community PwD or PwD–carer dyads
  • Hospital admission

  • ED visit

Hovsepian (2022) 39 North America 12 (9) 9472 Home/community‐based care models prioritizing needs and developing care plans. Usual care Community PwD or PwD–carer dyad
  • Hospital admission

  • LoS

Ma (2019) 5 North America 2 (0) 1300 Family‐centered function‐centered care or collaborative dementia care Usual care Acute care PwD or PwD–carer dyad
  • Hospital admission

  • Readmission

  • LoS

Casarez (2024) 41 North America 1 (0) 84 Family‐focused function‐centered care to maximize function and physical activity Usual care Acute care PwD and PwD‐ carer dyad
  • LoS

Packer (2019) 53 North America and Europe 8 (8) 1943 Collaborative care coordination, including education, caregiver coping skills, legal and financial advice, goal‐oriented support group, reassessments Usual care Community PwD and PwD–carer dyad
  • Hospital admission

  • LoS

Godard‐Sebillotte (2018) 45 North America and Europe and East Asia 11 (11) 2936 EPOC taxonomy: “delivery arrangements,” “financial arrangements,” “governance arrangements,” or “implementation strategies” Usual care Community PwD or PwD–carer dyad
  • Hospital admission

  • LoS

  • ED visit

Sawan (2021) 51 North America 1 (0) 1216 Discharge planning, follow‐ups, comprehensive assessment of carer stress and patients' behavioral and psychological condition, medication review, caregiver counseling, and reviewing medical regimen Usual care Community PwD and PwD–carer dyad
  • Hospital admission

Multidisciplinary teams (MDT)
Tunnard (2022) 40 North America and Europe 3 (1) 106+ Collaborative virtual (scheduled and unscheduled) MDT meetings to discuss care management options Standard care Care home Staff caring for PwD
  • Hospital admission

Ma (2019) 5 Europe 1 (1) 460 A pharmacist is included in the care team, completing medication reconciliations, medication reviews, and participating in ward rounds Usual care Acute care PwD
  • Readmission

Feast (2020) 19 Europe 1 (0) 101 Multidisciplinary postoperative program to reduce postoperative complications Usual care Acute care PwD
  • LoS

Packer (2019) 53 North America 1 (1) 100 Systematic multidisciplinary assessments in assisted living residences Usual care Care home PwD
  • Hospital admission

Godard‐Sebillotte (2019) 45 Europe 1 (1) 256 Comprehensive geriatric assessment by a geriatrician or old‐age psychiatrist before care home placement Usual care Community PwD
  • ED visits

Phelan (2015) 50 North America 1 (0) 100 Multidisciplinary assessments during relocation to assisted living Usual care Care home PwD
  • Hospital admission

  • ED visits

Andrews (2025) 42 Europe 1 (1) 429 Pharmacist‐led medication reconciliation and medication review Usual care Acute care PwD
  • Hospital admissions

  • ED visits

Lee (2025) 43 North America 1 (0) 365 Multicomponent recommendations by ER2 tool. Recommendations include (1) medication review by ED physician; (2) discharge planning team; (3) occupational therapy; (4) reorienting patient during temporal disorientation Usual care Acute care PwD
  • Hospital admissions

Smith (2025) 55 North America 1 (0) 977,946 Post‐acute home healthcare including skilled nursing, therapy, social work, and home healthcare services Skilled nursing facilities Community PwD
  • Readmission

Physical activity
De Souto Barreto (2020) 93 Europe 6 (6) 1312 Group‐based supervised multicomponent exercise training programs Non‐exercise group Long‐term care or community PwD
  • Hospital admission

Phelan (2015) 50 Europe 1 (1) 135 Home‐based occupational therapy with a caregiver for individuals at a memory clinic/day clinic in a geriatric department Not specified Community PwD or PwD– carer dyad
  • Hospital admission

Lee (2020) 25 Europe

1 (1)

210 Supervised moderate‐intensity exercise, including aerobic, strength training, and balance exercises Usual care Community PwD or PwD–carer dyad
  • Hospital admission

Packer (2019) 53 Europe 3 (3) 446 Physiotherapy and occupational therapy in home‐based and day care settings Usual care Community PwD
  • Hospital admission

  • LoS

Education/Training
Godard‐Sebillotte (2019) 45 Europe 1 (1) 390 Self‐management with educational material and meetings Usual care Community PwD or PwD–carer dyad
  • Hospital admissions

  • LoS

Casarez (2024) 41 Europe and Australia 2 (0) 729 Training program to improve dementia care practices or an integrated approach to support staff and promote confidence Before and after implementation Acute care PwD or staff caring for PwD
  • LoS

Andrews (2025) 42 Australia and East Asia 2 (0) 206 Education of MDT and pharmacist developed individualized deprescribing protocols, or education materials sent to general practitioners with anticholinergic medications tapered or replaced Before and after implementation or acute care Community Staff caring for PwD
  • Hospital admission

  • ED visits

Bocks (2025) 54 Australia 1 (1) 1304 IMPETUS‐D online training program with modules covering best practice palliative and end‐of‐life care, recognizing deterioration due to dementia versus delirium and recognizing dying Usual training Community Staff caring for PwD
  • Hospital admissions

Type of hospital setting
Reich (2022) 44 Europe 2 (0) 200 Single rooms versus multi‐bed wards Before implementation Acute care PwD
  • LoS

  • Discharge

McCausland (2018) 38 Europe 2 (1) 1500 Specialist inpatient dementia units Standard inpatient care Acute care PwD
  • Readmission

  • LoS

  • Discharge

Feast (2020) 19 Europe 1 (0) 48 Specialist cognitive geriatric unit Conventional geriatric care Acute care PwD
  • LoS

Lee (2025) 43 Europe 1 (0) 801 Geriatric emergency medicine unit for elderly patients Usual care Acute care PwD
  • Readmissions

Group activities
Feast (2020) 19 Europe 1 (0) 85 10‐week music program Usual care Acute care PwD
  • LoS

Reich (2022) 44 Europe 1 (0) 85 10‐week music program Before implementation Acute care PwD
  • LoS

Packer (2019) 53 Europe 2 (2) 213 Day‐care center three times a week offering social, physical, and occupational activities Usual care Community PwD–carer dyad
  • Hospital admission

Discharge
Sawan (2021) 51 Europe and East Asia 2 (0) 433 MDT administered intervention, including caregiver education and counseling, tailored medication management advice, and discharge planning Usual care Acute care or community PwD or PwD–carer dyad
  • Readmission

  • LoS

Ma (2019) 5 Europe 1 (0) 390 Post‐discharge telephone follow‐up Usual care Acute care PwD
  • Readmission

Palliative care
Quinn (2020) 37 Australia 1 (1) 64 Palliative Care Planning Coordinator performing Facilitated case conferencing at nursing homes Usual care Care home PwD
  • Hospital admission

  • ED visits

Ma (2019) 5 North America 1 (0) 368 Home‐ and clinic‐based palliative care provided by trained specialist palliative care teams. The program consists of in‐home medical consultation, ongoing evidence‐based prognostication, caregiver support, and advanced healthcare planning Usual care Community PwD
  • Readmission

Counseling
Packer (2019) 53 Europe 2 (2) 666 Individual and group‐based counseling sessions plus educational courses or reminiscence therapy for 12 weeks with rotating weekly topics Usual care Community PwD or PwD–carer dyad
  • Hospital admission

  • ED visits

Godard‐Sebilotte (2019) 45 North America and Europe 2 (2) 552 Individual and group‐based counseling sessions plus educational courses Usual care Community PwD or PwD‐ carer dyad
  • Hospital admission

  • LoS

Volunteering
Reich (2022) 44 Europe 1 (0) 16 Take part in activities with school‐aged volunteers 1 day per week for 2 h Before implementation Acute care PwD
  • Readmission

Feast (2020) 19 Australia 1 (0) 548 Person‐centered volunteer program to help with eating/drinking, interacting with others, engaging in therapeutic activities Usual care Acute care PwD
  • Readmission

Carer interventions
Godard‐Sebillotte (2019) 45 North America 1 (1) 197 REACH II caregiver intervention providing education, social support, cognitive strategies for reframing negative emotional responses and strategies for enhancing healthy behaviors Usual care Community Carers
  • Hospital admission

  • ED visits

Advance care planning (ACP)
Dixon (2018) 48 North America and Europe 6 (4) 479,231 ACP staff training program or ACP discussion/facilitation or written advance directives Before and after implementation Care home or community PwD or PwD–carer dyad
  • Hospital admission

  • LoS

  • ED visit

Abbreviations: ED, emergency department; LoS, length of stay; PwD, people with dementia.

The GRADE rating for each intervention within each review (Table S5) showed high certainty of evidence for findings from two reviews on case management and physical activity. All 11 primary studies in these reviews were RCTs, with 905 participants receiving case management and 1312 participants in the exercise program. Seven reviews provided moderate certainty of evidence, and these evaluated case management, palliative care, MDTs, and type of hospital setting interventions in 24 primary studies (21 RCTs) with a pooled sample of 10,904 participants. Twelve reviews had low certainty of evidence and evaluated case management, physical activity, MDTs, advance care planning (ACP), education/training, group activities, counseling, and carer interventions in 40 primary studies (33 RCTs) with 495,490 participants. Eight reviews had critically low certainty and evaluated case management, palliative care, type of hospital setting, MDTs, education/training, discharge, group activities, and volunteering in 19 primary studies (one RCT) with 975,980 participants. Common reasons for downgrading evidence GRADE were issues with risk of bias and imprecision.

3.1. Case management

Based on previous definitions, 46 , 56 , 57 case management was categorized as an intervention with a clinical lead (case manager) responsible for advocating for, planning, and facilitating healthcare services to support the individual and family member care needs to promote high‐quality outcomes; remote/virtual delivery of case management was assessed in some studies. Results are summarized in Table 2.

TABLE 2.

Summary of evidence and quality of findings for effect of case management interventions on hospitalization in people with dementia.

Quality No. studies (RCTs), sample size Intervention subtype Results

High

5 (5)

905

Case management Hospital admissions
  • No effect 30

    (OR 0.87 [0.59,1.3])

LoS
  • Increased

    Meta‐analysis of three studies 30 : (MD 0.63 [0.40, 0.86]) 59 , 60 , 61

  • Reduced in hospital units or residential homes in case management: 58

    • After 6 months (MD −5.8 [−7.93, −3.67])

    • After 12 months (MD −7.7 [−9.38, −6.02])

Moderate

15 (13)

7544

Case management Hospital admissions
  • No effect

    Meta‐analysis of three studies: (RR 1.00 [0.76, 1.33]) 31

    Individual studies: (RR 1.12 [0.87, 1.68]), 63 (RR 1.20 [0.64, 2.25]), 60 (RR 0.93 [0.69, 1.24]), 71 (RR 1.37 [0.38, 4.94]), 66 (RR 1.16 [0.67, 1.99]), 59 (RR 0.57 [0.27, 1.22]), 58 (RR 0.88 [0.35, 2.21]), 67 (RR 1.21 [0.87, 1.68]), 69 (RR 1.04 [0.93, 1.17]), 70 (MD −0.08 [−0.29, 0.13]), 65 (RR 1.86 [0.84, 4.09]), 72 (DID −1 [−13, 11]) 62

  • Reduced

    (RR 0.46 [0.23, 0.92]) – unpublished data 74

LoS
  • No effect

    (MD 0.03 [−0.25, 0.27]), 63 (MD −0.16 [−0.39, 0.07]), 64 (MD −0.15 [−0.51, 0.20]), 59 (MD −2.10 [−6.9, 2.70]), 58 (MD −1.5 [−6.14, 3.14]), 67 (MD 0.16 [−1.69, 1.91]), 69 (MD 0.06 [−0.10, 0.22]) 70

  • Reduced

    (MD −0.37 [−0.66, −0.08]), 68 (MD −0.34 [−0.57, 0.12]) – unpublished data 74

  • Increased

    (MD 3.80 [3.07, 4.53]) 72

ED visits
  • No effect

    (RR 0.73 [0.32, 1.63]), 58 (RR 0.80 [0.35, 1.84]), 67 (RR 1.35 [0.85, 2.15]), 68 (RR 1.06 [0.78, 1.44]), 69 (RR 0.84 [0.49, 1.44]), 72 (MD −0.17 [−0.56, 0.22]), 65 (DID −1 [−15, 12]) 62

  • Reduced

    (0.23 ± 0.59 vs 0.09 ± 0.32) 73

2 (2)

938

Virtual case management Hospital admissions
  • No effect

    (β 0.09 [−0.05, 0.2]) at 6 months, 80 (β −0.03 [−0.18, 0.12]) at 12 months 75

ED visits
  • Reduced

    (β −0.14 [−0.29, −0.01]) at 12 months 75

Low

16 (13)

7027

Case management Hospital admissions LoS ED visits Readmissions
  • Reduced in people with more severe dementia 71 , 76

3 (3)

4370

Virtual case management Hospital admissions
Critically low

2 (0)

1300

Fam‐FFC LoS Readmissions
Collaborative dementia care Hospital admissions; ED visits; readmissions

Note: 95% CIs in square brackets.

Abbreviations: β, beta coefficient; CI, confidence interval; DID, difference‐in‐differences estimate per 1000 patients; ED, emergency department; fam‐FFC, family‐focused function‐centered; LoS, length of stay; MD, mean difference; OR, odds ratio; PwD, people with dementia; RR, risk ratio.

3.1.1. High quality

One review of five studies examining the effects of case management interventions reported no significant reduction in hospital admissions. 30 One study in this review found a significant decrease in the number of days in a hospital unit or residential home in the case management group at 6 and 12 months, although it was not possible to differentiate hospital and residential home stays. 58 A meta‐analysis of three studies reported longer LoS in those who received case management than the control group. 59 , 60 , 61

3.1.2. Moderate quality

3.1.2.1. Case management

Thirteen studies reported no significant differences between groups for hospital admission, 58 , 59 , 60 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 10 studies found no significant difference between groups for ED visits, 58 , 65 , 67 , 68 , 69 , 72 , 73 and six studies found no significant difference between groups for LoS. 58 , 59 , 63 , 64 , 67 , 69 , 70 However, one review included unpublished data from a RCT that reported a significant reduction in hospital admissions and LoS in the case management group compared to controls. 74 Moreover, one study found greater LoS in the case management group, 72 while another found a small reduction in LoS for case management group. 68

3.1.2.2. Virtual case management

One RCT reported no significant effect of case management intervention on hospital admissions at either 6 or 12 months compared to the control group. 75

3.1.3. Low quality

3.1.3.1. Case management

Eight studies found no significant differences between groups for hospital admissions 60 , 62 , 63 , 64 , 65 , 66 , 69 , 76 and a small meta‐analysis found no effect of multifactorial interventions and treatments on hospital admissions 25 even after making adjustments in sensitivity analyses.

Hospital admissions for ambulatory care‐sensitive conditions decreased in the case management group compared to controls after 6 months. 77 The Healthy Aging Brain Centre reported reductions in ED visits, hospital admissions, and LoS compared to controls. 78 Another study also found a reduction in ED visits compared to the control group, 79 and unpublished data from two additional studies demonstrated weak effects on reduced LoS. 58 , 67 Moreover, among people with dementia with at least one hospital admission, those with severe cognitive impairment had fewer hospital admissions after 6 months compared to those with milder cognitive impairment. 71 , 76

3.1.3.2. Virtual case management

Three studies reported no significant effect of technology‐enabled case management on hospital admissions at 6‐, 12‐, or 24‐month follow‐ups. 75 , 80 , 81

3.1.4. Critically low quality

3.1.4.1. Family‐focused function‐centered care (fam‐FFC)

One study reported no significant difference in LoS between the fam‐FFC group and controls. However, people with dementia receiving fam‐FFC had a significantly reduced risk of 30‐day readmissions. 82

3.1.4.2. Collaborative dementia care

One study reported that people with dementia receiving collaborative dementia care had lower rates of readmission, ED visits, and hospital admissions compared to controls. 78

3.1.5. Summary

There was high‐quality evidence to suggest that case management is not effective in reducing hospital admissions and may increase LoS in people with dementia and moderate‐ and low‐certainty evidence suggesting virtual case management is also ineffective.

3.2. Multidisciplinary teams

Included MDT interventions varied in structure and composition, but these were often characterized by multidisciplinary services from various healthcare providers, including, neurologists, geriatricians, social workers, nurse practitioners, and physical/occupational therapists. 55 , 83 Results are summarized in Table 3.

TABLE 3.

Summary of evidence and quality of findings for effect of psychosocial interventions on hospitalization in people with dementia.

Intervention Quality

No. studies (RCTs),

sample size

Intervention subtype Results
Working with people with dementia and carers
Physical activity High

6 (6)

1312

Exercise program Hospital admissions
  • No effect: main analysis (RR 1.10 [0.85, 1.43]), sensitivity analyses (OR 1.21 [0.80, 1.83]) 36

Low

5 (5)

791

Physiotherapy and occupational therapy Hospital admissions
  • No effect: (RR 0.83 [0.30, 2.34]) 84 (RR 1.30 [0.63, 2.65]) 85

LoS
  • No effect: (MD 0.16 [−0.36, 0.03]) 53

Exercise program Hospital admissions
  • No effect: Home‐based exercise (IR 0.47 [0.31, 0.68]), group‐based exercise (IR 0.54 [0.46, 0.90]), control groups (IR 0.65 [0.46, 0.90]) 86

Group activities Low

2 (2)

213

Day care Hospital admissions
  • No effect: (RR 1.15 [0.70, 1.91]) 87 , 88

Critically low

1 (0)

85

Music program LoS
  • Reduced: (34.68 days after intervention vs 36.90 days before intervention), 89 discharges increased by 9.84% 89

Counseling Low

3 (3)

858

Individual and group counseling Hospital admissions
  • No effect: (RR 0.94 [0.77, 1.14]) at 3 years 90 (RR 0.81 [0.41, 1.60]) at 12 months 91

ED visits
  • No effect: (RR 1.00 [0.78, 1.27]) at 3 years 90

Reminiscence therapy Hospital admissions
  • No effect: (RR 1.17 [0.63, 2.20]) 92

Carer interventions Low

1 (1)

197

REACH‐II Hospital admissions
  • No effect: (RR 1.09 [0.77, 1.55]) at 12 months 93

ED visits
  • No effect: (RR 1.26 [0.95, 1.67]) at 12 months 93

ACP Low

6 (4)

479,231

ACP facilitation Hospital admissions
  • Reduced by 55% over 2 years 94

Written AD Hospital admissions
  • Increased by lack of a written AD: (ARR 1.15 [1.14, 1.17]) 95

LoS
  • Reduced with a written AD: (5.7 days (SD 12.6) versus 12.8 days (SD 20.9); p = 0.026) 96

Staff ACP training Hospital admissions LoS
Working with staff and organizational structures
MDT Moderate

2 (2)

858

Pharmacist‐led medication reviews ED visits Hospital admissions
  • No effect 100

  • Reduced after excluding individuals with heart failure 100

Low

5 (3)

1982

Pharmacist in MDT Readmission
  • Reduced medication‐related 30‐day readmissions: (5% vs 11% in controls, p = 0.03) 100

MDT during transition to assisted living Hospital admissions
  • No effect: (RR 0.65 [0.26, 1.65]) 101

Comprehensive geriatric assessment Hospital admissions
  • No effect: (RD 0.79 [0.50, 1.27]) at 6 months 102

ED visits
  • No effect: (RD 1.11 [0.44, 2.78]) 102

Readmission
Geriatric emergency medicine unit for elderly patients Hospital admissions
  • Increased: (57.8% vs 47.1% compared to standard ED care) 103

Readmission
  • Reduced: (OR 0.65 [0.46, 0.94] compared to standard ED care) 103

ER2 tool Hospital admissions LoS
  • Increased in ED: (∼4.28 to 5.56 h, p < 0.001) 104

Critically low

6 (1)

972,253

Virtual MDT Hospital admissions
Post‐operative MDT LoS
  • No effect: (Intervention 20.0 ± 12.0 days vs control 32.1 ± 35.3 days; p = 0.059) 108

MDT during relocation to assisted living Hospital admissions
  • No effect (p = 0.13) 101

ED visits
  • No effect (p = 0.80) 101

Home healthcare from MDT Readmission
  • No effect: (OR = 1.01 [1.00, 1.02]) in comparison with skilled nursing facility 109

Education/Training Low

2 (2)

596

Educational material Hospital admissions
  • No effect: (RR = 0.91 [0.74, 1.13]) 110

Medication review education Hospital admissions
Critically low

3 (1)

2033

Dementia training for staff Hospital admissions
  • No effect at 6 months 113

LoS
  • No effect but downward trend at end of intervention 114

  • Reduced by 6 days (p = 0.019) 115

Type of hospital setting Moderate

2 (1)

1500

Specialist inpatient dementia units Hospital admissions
  • Reduced (22% in SIDU vs 28.3% in SWC; p = 0.25) 116

LoS
  • No effect: (SIDU 28.5 days (SD 31.4) versus SWC 25.1 days (SD 48.7); p = 0.47) 116 (SIDU 16 median days vs. SWC 16 median days; p = 0.32) 117

Readmission
  • No effect: (32% in SIDU vs 35% in SWC) 117

Critically low

3 (0)

248

Single versus multi‐bed wards LoS
  • Increased: 62.2 days in single rooms versus 42.5 in multi‐bed wards p = 0.027, 118 39.7 days in single rooms versus 21.8 in multi‐bed wards, p = 0.001 119

Readmission
  • No effect after 30 days in single rooms (p = 0.335) 118

Cognitive geriatric unit LoS
  • Increased: (19.9 ± 4.9 days vs 17.7 ± 4.7 days on control ward) 120

Discharge intervention Critically low

2 (0)

433

Post‐discharge follow‐up LoS
  • Reduced (25 days vs 31 days in control group; p = 0.005) 121

Readmission
  • No effect after 30 days: (8.4% vs 8.0% before intervention; p = 0.82) 122

Palliative care Moderate

1 (1)

64

Nursing home‐based palliative care Hospital admissions
  • No effect (OR = 1.06 [0.45, 2.50]) 123

ED visits
  • No effect (OR = 0.89 [0.35, 2.25]) 123

Critically low

1 (0)

368

Home‐based palliative care Readmission
  • Reduced (11% vs 35% in matched controls; p = 0.01) 124

Volunteer Critically low

2 (0)

564

Person‐centered volunteers LoS
  • Increased (z = 3.22; p = 0.001; d = 0.30) 89

Readmission
  • No discharged patients readmitted within 28 days 125

Note: 95% confidence intervals presented are in square brackets.

Abbreviations: ACP, advance care planning; AD, advance directives; ARR, adjusted risk ratio; ED, emergency department; ER2 tool, Emergency Room Evaluation and Recommendations Tool; ICU, intensive care unit; IR, incidence rate; LoS, length of stay; MD, mean difference; MDT, multidisciplinary team; OR, odds ratio; RD, risk difference; REACH‐II, Resources for Enhancing Alzheimer's Caregiver Health; RR, risk ratio; SD, standard deviation; SIDU, specialist inpatient dementia units; SWC, standard ward care.

3.2.1. Moderate quality

Two RCTs (n = 858) found no effect of pharmacist‐led medication reviews on hospital admissions or ED visits, 99 , 100 but one study found a significant decrease in hospitalization after adjusting for heart failure. 100

3.2.2. Low quality

One RCT (n = 460) found that including a clinical pharmacist in the hospital MDT produced significantly lower medication‐related 30‐day readmissions compared to control. 100 However, comprehensive geriatric assessments and MDT assistance during transition to assisted living did not affect hospitalization. 101 , 102

3.2.3. Critically low quality

Video consultations with MDT showed significant evidence of reduced hospital admissions. 105 , 106 , 107 However, post‐operative MDT interventions, MDT during relocation to assisted living, and home healthcare groups found no significant reductions in hospitalization. 101 , 108 , 109

3.2.4. Summary

Moderate‐quality evidence suggests pharmacist‐led medication reviews can reduce hospitalization in dementia only after adjusting for physical comorbidities.

3.3. Physical activity

Physical activity interventions included an intervention focused on improving strength, mobility, and balance through exercise groups or physical therapy programs. Results are summarized in Table 3.

3.3.1. High quality

One review of six RCTs examining the effects of supervised exercise programs at home found no significant impact on hospitalizations compared to controls, even after conducting sensitivity analysis. 126

3.3.2. Low quality

One RCT (n = 210) also included in the high‐quality review found hospitalization did not differ across home‐based exercise, group‐based exercise, or control groups. 86 A further RCT (n = 236) found there were also no significant reductions in hospital admissions after physiotherapy and occupational therapy interventions, but there was weak evidence that physiotherapy and occupational therapy were associated with small reductions in LoS. 85

3.3.3. Summary

There is high‐quality evidence that, while in general supervised exercise programs for people with dementia may be helpful in other domains, they do not decrease the likelihood of hospitalizations.

3.4. Education/training

Interventions were categorized as education/training programs provided they aimed to improve staff confidence, knowledge or understanding of dementia care through face‐to‐face training, collaborative meetings, or reading materials. Results are summarized in Table 3.

3.4.1. Low quality

Three RCTs (n = 596) assessing educational materials, meetings with healthcare professionals produced, and medication review education found no significant association with hospital admissions compared to controls. 110 , 111 , 112

3.4.2. Critically low quality

While one NRSI (n = 68) reported dementia training for staff produced a significant reduction in LoS, 115 another NRSI (n = 661) reported no significant difference in LoS, but a downward trend was established toward the end of the intervention. 114 One RCT (n = 1304) found no effect for nursing home staff training on hospital admissions at 6 months. 113

3.4.3. Summary

There is no good evidence of an effect of education or training on hospitalization; however, the evidence base is limited.

3.5. Type of hospital setting

Type of hospital setting interventions focused on situational variables in acute or community care that differed from regular care settings or were tailored to people with dementia. Results are summarized in Table 3.

3.5.1. Moderate quality

Two studies (n = 1500) found no significant difference reported between specialist inpatient dementia units and control groups for LoS. 116 , 117 The RCT (n = 600) found non‐significant reductions in readmission rates, 117 and a NRSI (n = 900) reported fewer short‐term admissions in the intervention group compared to controls. 116

3.5.2. Critically low quality

Two NRSIs (n = 200) examining single‐bed rooms were associated with significantly increased LoS compared to multi‐bed wards, 118 , 119 but there was no significant difference in 30‐day readmissions. 118 Cognitive Geriatric Units (NRSI, n = 48) were also associated with increased LoS compared to control. 120

3.5.3. Summary

There was a lack of good‐quality evidence, but to date there is no evidence that the type of hospital setting affects hospitalization.

3.6. Group activities

Group activities referred to social activities based within the community or residential care settings. Results are summarized in Table 3.

3.6.1. Low quality

Two RCTs (n = 213) found day care interventions had no effect on hospitalization compared to control. 87 , 88

3.6.2. Critically low quality

One NRSI (n = 85) found music programs demonstrated a small reduction in LoS and an increase in the total number of discharges compared to the control group. 89

3.6.3. Summary

There is no good evidence of an effect of group activities on hospitalization; however, the evidence base is limited.

3.7. Discharge intervention

Discharge interventions consisted of follow‐ups from healthcare providers, guidance for people with dementia and caregivers, medication management, or discharge planning for people with dementia discharged from acute care. Results are summarized in Table 3.

3.7.1. Critically low quality

One NRSI (n = 390) found no significant differences between post‐discharge and control groups for 30‐day ED readmissions. 122 Another NRSI (n = 43) reported evidence of a significant reduction in LoS. 121

3.7.2. Summary

There is no good evidence of an effect of discharge intervention on hospitalization; however, the evidence base is limited.

3.8. Palliative care

Based on previous definitions, palliative care interventions were categorized as interdisciplinary patient‐centered care focusing on physical, psychosocial, and spiritual needs with careful reviews and management to best promote quality of life. 127 , 128 Results are summarized in Table 3.

3.8.1. Moderate quality

One RCT (n = 64) reported no significant association between palliative care and ED visits or hospital admissions compared to the control group. 123

3.8.2. Critically low quality

One observational study (n = 368) reported that people with dementia receiving home‐based palliative care had a significantly lower risk of readmissions compared to matched controls. 124

3.8.3. Summary

There is no good‐quality evidence that palliative care reduces hospital admissions or ED visits on hospitalization; however, the evidence base is limited.

3.9. Counseling

Counseling interventions included individual or group‐based talking sessions led and managed by healthcare providers. Results are summarized in Table 3.

3.9.1. Low quality

Three RCTs (n = 858) found no significant effect for individual/group counseling or reminiscence therapy on hospitalization. 90 , 91 , 92

3.9.2. Summary

There is no good evidence for an effect of counseling on hospitalization; however, the evidence base is limited.

3.10. Volunteers

Volunteer programs were categorized as interventions focusing on social connections and emotional support between volunteers and PwD or caregivers through activities or discussions to enhance quality of life. Results are summarized in Table 3.

3.10.1. Critically low

All patients (n = 16) discharged following a meaningful engagement intervention remained out of the hospital for over 28 days. 89 Also, the person‐centered volunteer intervention had a significantly longer LoS than the control group. 125

3.10.2. Summary

There is no good evidence of an effect of volunteers on hospitalization; however, the evidence base is limited.

3.11. Carer intervention

Carer interventions refer to individualized psychosocial support for caregivers of people with dementia including but not limited to social support, stress management, or skills training. Results are summarized in Table 3.

3.11.1. Low quality

One RCT (n = 197) found carer interventions did not have a significant effect on ED visits or hospital admissions after 12 months. 93

3.11.2. Summary

There is no good evidence of an effect of carer interventions on hospitalization; however, the evidence base is limited.

3.12. Advance care plans (ACP)

Advance care planning aims to offer the opportunity to have meaningful discussions planning future care and support, including medical treatment and end‐of‐life support, while people have the mental capacity to do so. 129 Results are summarized in Table 3.

3.12.1. Low quality

In one review of six studies (four RCTs) and 479,231 participants, ACP facilitation was found to reduce hospital admissions by 55% over 2 years 94 and written directives found to reduce LoS. 96 , 130 Also, the absence of an advance directive was found to increase the risk of hospital admission. 95 However, training programs for delivering ACP found mixed effects on the LoS compared to control. 97

3.12.2. Summary

There was only low‐quality evidence of ACP and written directives, but results were promising, suggesting they reduced hospital admission. Training staff to increase delivery of ACP had mixed results.

4. DISCUSSION

Our umbrella review is the first to examine the effects of psychosocial and healthcare interventions on reducing hospitalization in PwD. We found 25 systematic reviews, including 77 unique studies (RCTs = 47; NRSIs = 30) with 1,483,077 participants. Overall, there was high certainty that case management and exercise programs had no significant effect on hospital admissions or LoS. The most promising interventions were ACP facilitation, which resulted in significantly reduced hospitalizations and including clinical pharmacists in MDT interventions, which significantly reduced medication‐related readmissions, but both had low/moderate certainty of evidence for efficacy. There was moderate‐certainty evidence that palliative care did not reduce hospitalizations. Other interventions, including education, group activities, counseling, and carer interventions, were not shown to affect hospitalization, but there was low certainty for this evidence.

We conducted a comprehensive search and employed a rigorous systematic approach to data collection and synthesis. Nonetheless, there are some important limitations. First, most evidence was from high‐income countries, and we cannot generalize our findings to low‐ and middle‐income countries or healthcare systems where the availability of services and cultural considerations about care at home are likely to differ significantly. Second, the heterogeneity across interventions and outcomes prevented us from meta‐analyzing findings and categorizing results definitively by intervention and outcome. Third, by definition, umbrella reviews omit recent primary studies of potential value, and therefore our review cannot include the full scope of primary research despite updated searches. Fourth, our use of a single reviewer to assign GRADE ratings to included studies has the potential for error, though the structured GRADE rating checklist we used and team discussions mitigated this. Fifth, while we considered confounders during GRADE assessments, we were unable to establish the influence of confounders on the association between interventions and hospitalization in PwD in non‐randomized studies of interventions. Sixth, several reviews included unpublished data obtained through personal correspondence, and despite contacting authors for clarification, we cannot validate these data and results. Seventh, little research evidence was of high certainty, meaning we cannot establish the true effect of each intervention on hospitalization in dementia without further robust and high‐quality RCTs. Finally, there is a lack of data on cost and cost‐effectiveness, meaning it is not possible to draw conclusions about the economic implications of interventions aimed at reducing hospitalizations.

The most studied intervention was case management, reflecting the expectation that the presence of a clinical lead (case manager) responsible for advocating for, planning, and facilitating access to healthcare services to support the individual and family would be effective in reducing hospitalization. However, we did not find this; instead, there was high‐quality evidence of a small increase in LoS in those receiving case management, possibly due to case managers facilitating healthcare services to support the individual and family members and leading to greater health service use.

Our findings of reduced hospitalization following ACP facilitation and written directives are consistent with a previous review. 131 Training programs were not effective, possibly because of varied delivery settings or funding, as staff turnover, staff shortages, and organizational culture play a critical role in the successful implementation of ACP. 132

Previous systematic reviews assessing exercise effects on hospitalization in older adults found a reduction in the number of falls following exercise interventions. 36 , 133 However, in our analysis of studies of PwD, we found strong evidence that these programs did not reduce hospitalization, suggesting that there may be additional components required beyond general exercise programs to reduce hospitalization in PwD. Studies of general older adult populations had similarly found that palliative care had a significant effect on hospitalization, 134 , 135 but we found with moderate certainty that there was no effect in PwD. This suggests that palliative care needs to be specifically tailored for PwD, such as using specific protocols for observing pain and distress and facilitating decisions with carers to initiate palliative treatment, particularly where people with dementia lack mental capacity. 136

The low certainty of evidence examining the effects of MDTs on hospitalization in dementia is related to small studies lacking sufficient statistical power. However, one review stated that included primary studies only measured “acute hospital use,” meaning potentially avoidable admissions might have been excluded, 45 which may explain the absence of an observed association. Previous research on the impact of specialist wards on hospitalization in dementia indicated a potential reduction in readmission 137 and non‐significant reductions in LoS. 138 Our results are in line with this, but there is insufficient evidence for firm conclusions.

As the evidence assessing the remaining psychosocial interventions is of critically low quality, we are unable to make any recommendations based on the literature. Consequently, further high‐quality RCTs implementing standardized interventions and outcomes is required to determine their efficacy in reducing hospitalization in PwD.

4.1. Conclusion and recommendations

This umbrella review has shown that current evidence for psychosocial and healthcare interventions in reducing hospitalizations in dementia is insufficient to formulate definitive guidelines for commissioners and policymakers. Clinicians may, however, consider ACP or written directives as effective interventions for possibly reducing avoidable admissions, although this evidence is currently of low certainty. Including pharmacists in MDT interventions may also help reduce hospitalizations in dementia care. However, clinicians should acknowledge the high‐certainty evidence suggesting case management and exercise programs are ineffective in reducing hospitalizations in PwD. Robust RCTs will be required to improve the certainty of positive recommendations. Specifically, researchers should focus on interventions that show promise but lack sufficient high‐quality evidence to support them, such as ACP, MDT interventions, and discharge interventions. Moreover, detailed descriptions of interventions and outcomes using standardized checklists, such as the template for intervention description and replication (TIDieR), are needed to reduce heterogeneity and determine the true efficacy of each intervention component. Researchers should also explore the efficacy of these interventions across a broad range of countries and their healthcare systems to establish effectiveness in more diverse settings.

CONFLICT OF INTEREST STATEMENT

G.L. has received grants from University College London (UCL) Hospitals National Institute for Health and Care Research (NIHR) Biomedical Research Centre, NIHR, North Thames NIHR Applied Research Collaboration, the Alzheimer's Association and Brain Canada, the Norwegian Research Council, Wellcome Trust, payment for presentations by Fondazione Prada, and travel support for attending meetings from global education and career consultants. N.M. has received grants from NIHR, NIHR Three Schools funding, and Alzheimer's Research UK and consulted for Glaxo SmithKline on virus‐related dementia risk. C.R. is supported by the Makaton Charity. K.W. has received grants from NIHR and the Alzheimer's Society. A.S. has received grants from The Geller Commission, the Wellcome Trust, the Alzheimer's Association, and Brain Canada and NIHR and an honorarium for a presentation from Fondazione Prada. C.H., N.A., D.D., A.F.‐S., C.G., S.G., and M.H. have nothing to declare. Author disclosures are available in the Supporting Information.

Supporting information

Supporting Information

ALZ-22-e71323-s001.docx (78.8KB, docx)

Supporting Information

ALZ-22-e71323-s002.pdf (5.4MB, pdf)

ACKNOWLEDGMENT

This project was funded by a philanthropic donation from Mr. Laurence Geller CBE.

Howard C, Fernández‐Sanlés A, Abukar N, et al. The effect of psychosocial and healthcare interventions on reducing hospitalization in people with dementia: an umbrella review. Alzheimer's Dement. 2026;22:e71323. 10.1002/alz.71323

Trial Registration: PROSPERO number: CRD42024604296

REFERENCES

  • 1. Nichols E, Steinmetz JD, Vollset SE, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):E105‐E125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Shepherd H, Livingston G, Chan J, Sommerlad A. Hospitalisation rates and predictors in people with dementia: a systematic review and meta‐analysis. BMC Med. 2019;17(1):130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Alzheimer's Society, Carnall Farrar . The Economic Impact of Dementia. 2024. Accessed February 28, 2026. Available from: https://www.alzheimers.org.uk/sites/default/files/2024‐05/the‐annual‐costs‐of‐dementia.pdf
  • 4. Browne B, Ali K, Ford E, Tabet N. Determinants of hospital readmissions in older people with dementia: a narrative review. BMC Geriatr. 2024;24(1):336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Ma C, Bao S, Dull P, Wu B, Yu F. Hospital readmission in persons with dementia: a systematic review. Int J Geriatr Psychiatry. 2019;34(8):1170‐1184. [DOI] [PubMed] [Google Scholar]
  • 6. Afonso‐Argiles FJ, Meyer G, Stephan A, et al. Emergency department and hospital admissions among people with dementia living at home or in nursing homes: results of the European RightTimePlaceCare project on their frequency, associated factors and costs. BMC Geriatr. 2020;20(1):453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Barry LE, Carter L, Nianogo R, O'Neill C, O'Shea E, O'Neill S. The association of comorbid dementia with length of stay, cost and mortality among older adults in US acute hospitals: an observational study. Arch Gerontol Geriatr. 2024;125:105487. [DOI] [PubMed] [Google Scholar]
  • 8. Butcher L. Caring for patients with dementia in the acute care setting. Br J Nurs. 2018;27(7):358‐362. [DOI] [PubMed] [Google Scholar]
  • 9. Dewing J, Dijk S. What is the current state of care for older people with dementia in general hospitals? A literature review. Dementia (London). 2016;15(1):106‐124. [DOI] [PubMed] [Google Scholar]
  • 10. Tropea J, LoGiudice D, Liew D, Gorelik A, Brand C. Poorer outcomes and greater healthcare costs for hospitalised older people with dementia and delirium: a retrospective cohort study. Int J Geriatr Psychiatry. 2017;32(5):539‐547. [DOI] [PubMed] [Google Scholar]
  • 11. Petty S, Dening T, Griffiths A, Coleston DM. Meeting the emotional needs of hospital patients with dementia: a freelisting study with ward staff. Gerontologist. 2020;60(1):155‐64. [DOI] [PubMed] [Google Scholar]
  • 12. Bail K, Berry H, Grealish L, et al. Potentially preventable complications of urinary tract infections, pressure areas, pneumonia, and delirium in hospitalised dementia patients: retrospective cohort study. BMJ Open. 2013;3(6):e002770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Everall AC, Guilcher SJT, Cadel L, Asif M, Li J, Kuluski K. Patient and caregiver experience with delayed discharge from a hospital setting: a scoping review. Health Expect. 2019;22(5):863‐873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Jackson TA, Gladman JR, Harwood RH, et al. Challenges and opportunities in understanding dementia and delirium in the acute hospital. PLoS Med. 2017;14(3):e1002247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Knox S, Downer B, Haas A, Middleton A, Ottenbacher KJ. Dementia severity associated with increased risk of potentially preventable readmissions during home health care. J Am Med Dir Assoc. 2020;21(4):519‐24 e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Rosvik J, Rokstad AMM. What are the needs of people with dementia in acute hospital settings, and what interventions are made to meet these needs? A systematic integrative review of the literature. BMC Health Serv Res. 2020;20(1):723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Bradshaw LE, Goldberg SE, Lewis SA, et al. Six‐month outcomes following an emergency hospital admission for older adults with co‐morbid mental health problems indicate complexity of care needs. Age Ageing. 2013;42(5):582‐588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Manietta C, Purwins D, Reinhard A, Knecht C, Roes M. Characteristics of dementia‐friendly hospitals: an integrative review. BMC Geriatr. 2022;22(1):468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Feast AR, White N, Candy B, Kupeli N, Sampson EL. The effectiveness of interventions to improve the care and management of people with dementia in general hospitals: a systematic review. Int J Geriatr Psychiatry. 2020;35(5):463‐488. [DOI] [PubMed] [Google Scholar]
  • 20. Griffiths A, Knight A, Harwood R, Gladman JR. Preparation to care for confused older patients in general hospitals: a study of UK health professionals. Age Ageing. 2014;43(4):521‐527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Godard‐Sebillotte C, Strumpf E, Sourial N, Rochette L, Pelletier E, Vedel I. Primary care continuity and potentially avoidable hospitalization in persons with dementia. J Am Geriatr Soc. 2021;69(5):1208‐1220. [DOI] [PubMed] [Google Scholar]
  • 22. Gungabissoon U, Perera G, Galwey NW, Stewart R. Potentially avoidable causes of hospitalisation in people with dementia: contemporaneous associations by stage of dementia in a South London clinical cohort. BMJ Open. 2022;12(4):e055447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Bickel H, Hendlmeier I, Hessler JB, et al. The prevalence of dementia and cognitive impairment in hospitals. Dtsch Arztebl Int. 2018;115(44):733‐740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Phelan EA, Borson S, Grothaus L, Balch S, Larson EB. Association of incident dementia with hospitalizations. JAMA. 2012;307(2):165‐172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Lee DA, Tirlea L, Haines TP. Non‐pharmacological interventions to prevent hospital or nursing home admissions among community‐dwelling older people with dementia: a systematic review and meta‐analysis. Health Soc Care Community. 2020;28(5):1408‐1429. [DOI] [PubMed] [Google Scholar]
  • 26. Belbasis L, Bellou V, Ioannidis JPA. Conducting umbrella reviews. BMJ Med. 2022;1(1):e000071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Gates M, Gates A, Pieper D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022;378:e070849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276‐282. [PMC free article] [PubMed] [Google Scholar]
  • 29. Higgins J, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane; 2024. Accessed February 28, 2026. Available from: www.cochrane.org/handbook [Google Scholar]
  • 30. Reilly S, Miranda‐Castillo C, Malouf R, et al. Case management approaches to home support for people with dementia. Cochrane Database Syst Rev. 2015;1(1):CD008345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Tam‐Tham H, Cepoiu‐Martin M, Ronksley PE, Maxwell CJ, Hemmelgarn BR. Dementia case management and risk of long‐term care placement: a systematic review and meta‐analysis. Int J Geriatr Psychiatry. 2013;28(9):889‐902. [DOI] [PubMed] [Google Scholar]
  • 32. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non‐randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924‐926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383‐394. [DOI] [PubMed] [Google Scholar]
  • 35. Granholm A, Alhazzani W, Moller MH. Use of the GRADE approach in systematic reviews and guidelines. Br J Anaesth. 2019;123(5):554‐559. [DOI] [PubMed] [Google Scholar]
  • 36. de Souto Barreto P, Rolland Y, Vellas B, Maltais M. Association of long‐term exercise training with risk of falls, fractures, hospitalizations, and mortality in older adults: a systematic review and meta‐analysis. JAMA Intern Med. 2019;179(3):394‐405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Quinn KL, Stukel T, Stall NM, et al. Association between palliative care and healthcare outcomes among adults with terminal non‐cancer illness: population based matched cohort study. BMJ. 2020;370:m2257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. McCausland BMS, Patel HP, Amin J, Baldwin DS, Loughran K, Osman‐Hicks VC. A systematic review of specialist inpatient dementia care services versus standard inpatient dementia care in acute hospitals. Aging Clin Exp Res. 2019;31(5):595‐610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Hovsepian V, Bilazarian A, Schlak AE, Sadak T, Poghosyan L. The impact of ambulatory dementia care models on hospitalization of persons living with dementia: a systematic review. Res Aging. 2022;44(7‐8):560‐572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Tunnard I, Gillam J, Harvey C, et al. The acceptability and effectiveness of eHealth interventions to support assessment and decision‐making for people with dementia living in care homes: a systematic review. Front Dement. 2022;1:977561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Casarez A, Smith JG. Associations between hospital organizational features, person‐centred care and nurse‐sensitive outcomes for persons with dementia in acute care: a systematic literature review. J Adv Nurs. 2024;80(10):3915‐3936. [DOI] [PubMed] [Google Scholar]
  • 42. Andrews N, Brooks C, Board M, et al. Medicine optimisation and deprescribing intervention outcomes for older people with dementia or mild cognitive impairment: a systematic review. Drugs Aging. 2025;42(4):275‐294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Lee S, Suh M, Ragsdale L, et al. A systematic review of interventions for persons living with dementia: the Geriatric ED guidelines 2.0. Acad Emerg Med. 2025;19:19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Reich CD, Lyons H, Holroyd‐Leduc JM. Optimizing the physical & social environment within hospitals for patients with dementia: a systematic review. Can Geriatr J. 2022;25(2):222‐232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Godard‐Sebillotte C, Le Berre M, Schuster T, Trottier M, Vedel I. Impact of health service interventions on acute hospital use in community‐dwelling persons with dementia: a systematic literature review and meta‐analysis. PLoS One. 2019;14(6):e0218426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Khanassov V, Vedel I, Pluye P. Barriers to implementation of case management for patients with dementia: a systematic mixed studies review. Ann Fam Med. 2014;12(5):456‐465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Pimouguet C, Lavaud T, Dartigues JF, Helmer C. Dementia case management effectiveness on health care costs and resource utilization: a systematic review of randomized controlled trials. J Nutr Health Aging. 2010;14(8):669‐676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Dixon J, Karagiannidou M, Knapp M. The effectiveness of advance care planning in improving end‐of‐life outcomes for people with dementia and their carers: a systematic review and critical discussion. J Pain Symptom Manage. 2018;55(1):132‐50 e1. [DOI] [PubMed] [Google Scholar]
  • 49. Frost R, Walters K, Aw S, et al. Effectiveness of different post‐diagnostic dementia care models delivered by primary care: a systematic review. Br J Gen Pract. 2020;70(695):e434‐e441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Phelan EA, Debnam KJ, Anderson LA, Owens SB. A systematic review of intervention studies to prevent hospitalizations of community‐dwelling older adults with dementia. Med Care. 2015;53(2):207‐213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Sawan MJ, Wennekers D, Sakiris M, Gnjidic D. Interventions at hospital discharge to guide caregivers in medication management for people living with dementia: a systematic review. J Gen Intern Med. 2021;36(5):1371‐1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Demanes A, Ward KT, Wang AT, Hess M. Systematic review of dementia support programs with multicultural and multilingual populations. Geriatrics (Basel). 2021;7(1):8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Packer R, Ben Shlomo Y, Whiting P. Can non‐pharmacological interventions reduce hospital admissions in people with dementia? A systematic review. PLoS One. 2019;14(10):e0223717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Bocks L, Viengkham C, Powell M, et al. Registered nurse‐led assessments in Australian residential aged care homes: a scoping review. J Adv Nurs. 2026;82(1):81‐108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Smith JM, Burgdorf JG, Riser TJ, Ryvicker M. Skilled home healthcare utilization and outcomes for older adults with dementia: a scoping review. J Am Geriatr Soc. 2025;73(2):612‐625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Giardino AP, De Jesus O. Case Management. StatPearls; 2025. [Google Scholar]
  • 57. Case Management Society of America . What is a Case Manager? 2017. Accessed February 28, 2026. Available from: https://cmsa.org/who‐we‐are/what‐is‐a‐case‐manager/
  • 58. Chien WT, Lee YM. A disease management program for families of persons in Hong Kong with dementia. Psychiatr Serv. 2008;59(4):433‐436. [DOI] [PubMed] [Google Scholar]
  • 59. Eloniemi‐Sulkava U, Saarenheimo M, Laakkonen ML, et al. Family care as collaboration: effectiveness of a multicomponent support program for elderly couples with dementia. Randomized controlled intervention study. J Am Geriatr Soc. 2009;57(12):2200‐2208. [DOI] [PubMed] [Google Scholar]
  • 60. Callahan CM, Boustani MA, Unverzagt FW, et al. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA. 2006;295(18):2148‐2157. [DOI] [PubMed] [Google Scholar]
  • 61. Jansen AP, van Hout HP, Nijpels G, et al. Effectiveness of case management among older adults with early symptoms of dementia and their primary informal caregivers: a randomized clinical trial. Int J Nurs Stud. 2011;48(8):933‐943. [DOI] [PubMed] [Google Scholar]
  • 62. Jennings LA, Laffan AM, Schlissel AC, et al. Health care utilization and cost outcomes of a comprehensive dementia care program for medicare beneficiaries. JAMA Intern Med. 2019;179(2):161‐166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Amjad H, Wong SK, Roth DL, et al. Health services utilization in older adults with dementia receiving care coordination: the MIND at home trial. Health Serv Res. 2018;53(1):556‐579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Duru OK, Ettner SL, Vassar SD, Chodosh J, Vickrey BG. Cost evaluation of a coordinated care management intervention for dementia. Am J Manag Care. 2009;15(8):521‐528. [PMC free article] [PubMed] [Google Scholar]
  • 65. Bass DM, Clark PA, Looman WJ, McCarthy CA, Eckert S. The Cleveland Alzheimer's managed care demonstration: outcomes after 12 months of implementation. Gerontologist. 2003;43(1):73‐85. [DOI] [PubMed] [Google Scholar]
  • 66. Kohler L, Meinke‐Franze C, Hein J, et al. Does an interdisciplinary network improve dementia care? Results from the IDemUck‐study. Curr Alzheimer Res. 2014;11(6):538‐548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Chien WT, Lee IY. Randomized controlled trial of a dementia care programme for families of home‐resided older people with dementia. J Adv Nurs. 2011;67(4):774‐787. [DOI] [PubMed] [Google Scholar]
  • 68. Thyrian JR, Hertel J, Wucherer D, et al. Effectiveness and safety of dementia care management in primary care: a randomized clinical trial. JAMA Psychiatry. 2017;74(10):996‐1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Samus QM, Johnston D, Black BS, et al. A multidimensional home‐based care coordination intervention for elders with memory disorders: the maximizing independence at home (MIND) pilot randomized trial. Am J Geriatr Psychiatry. 2014;22(4):398‐414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Rubenstein LZ, Alessi CA, Josephson KR, Trinidad Hoyl M, Harker JO, Pietruszka FM. A randomized trial of a screening, case finding, and referral system for older veterans in primary care. J Am Geriatr Soc. 2007;55(2):166‐174. [DOI] [PubMed] [Google Scholar]
  • 71. Bass DM, Judge KS, Maslow K, et al. Impact of the care coordination program “Partners in Dementia Care” on veterans' hospital admissions and emergency department visits. Alzheimers Dement (N Y). 2015;1(1):13‐22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Meeuwsen E, Melis R, van der Aa G, et al. Cost‐effectiveness of one year dementia follow‐up care by memory clinics or general practitioners: economic evaluation of a randomised controlled trial. PLoS One. 2013;8(11):e79797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Saxena N, George PP, Teo KW, et al. Evaluation of an integrated primary care‐led dementia shared care program in Singapore: an effectiveness and cost‐effectiveness study. Geriatr Gerontol Int. 2018;18(3):479‐486. [DOI] [PubMed] [Google Scholar]
  • 74. Michalowsky B, Flessa S, Eichler T, et al. Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi‐trial. Eur J Health Econ. 2018;19(1):87‐102. [DOI] [PubMed] [Google Scholar]
  • 75. Possin KL, Merrilees JJ, Dulaney S, et al. Effect of collaborative dementia care via telephone and internet on quality of life, caregiver well‐being, and health care use: the care ecosystem randomized clinical trial. JAMA Intern Med. 2019;179(12):1658‐1667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Clark PA, Bass DM, Looman WJ, McCarthy CA, Eckert S. Outcomes for patients with dementia from the Cleveland Alzheimer's Managed Care Demonstration. Aging Ment Health. 2004;8(1):40‐51. [DOI] [PubMed] [Google Scholar]
  • 77. Clevenger CK, Cellar J, Kovaleva M, Medders L, Hepburn K. Integrated memory care clinic: design, implementation, and initial results. J Am Geriatr Soc. 2018;66(12):2401‐2407. [DOI] [PubMed] [Google Scholar]
  • 78. Boustani MA, Sachs GA, Alder CA, et al. Implementing innovative models of dementia care: the Healthy Aging Brain Center. Aging Ment Health. 2011;15(1):13‐22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Daaleman TP, Ernecoff NC, Kistler CE, Reid A, Reed D, Hanson LC. The impact of a community‐based serious illness care program on healthcare utilization and patient care experience. J Am Geriatr Soc. 2019;67(4):825‐830. [DOI] [PubMed] [Google Scholar]
  • 80. Wray LO, Shulan MD, Toseland RW, Freeman KE, Vasquez BE, Gao J. The effect of telephone support groups on costs of care for veterans with dementia. Gerontologist. 2010;50(5):623‐631. [DOI] [PubMed] [Google Scholar]
  • 81. Dorr DA, Wilcox AB, Brunker CP, Burdon RE, Donnelly SM. The effect of technology‐supported, multidisease care management on the mortality and hospitalization of seniors. J Am Geriatr Soc. 2008;56(12):2195‐2202. [DOI] [PubMed] [Google Scholar]
  • 82. Boltz M, Chippendale T, Resnick B, Galvin JE. Testing family‐centered, function‐focused care in hospitalized persons with dementia. Neurodegener Dis Manag. 2015;5(3):203‐215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Grand JH, Caspar S, Macdonald SW. Clinical features and multidisciplinary approaches to dementia care. J Multidiscip Healthc. 2011;4:125‐147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Graff MJ, Adang EM, Vernooij‐Dassen MJ, et al. Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. BMJ. 2008;336(7636):134‐138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Voigt‐Radloff S, Graff M, Leonhart R, et al. A multicentre RCT on community occupational therapy in Alzheimer's disease: 10 sessions are not better than one consultation. BMJ Open. 2011;1(1):e000096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Pitkala KH, Poysti MM, Laakkonen ML, et al. Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial. JAMA Intern Med. 2013;173(10):894‐901. [DOI] [PubMed] [Google Scholar]
  • 87. Engedal K. Day care for demented patients in general nursing homes. Effects on admissions to institutions and mental capacity. Scand J Prim Health Care. 1989;7(3):161‐166. [DOI] [PubMed] [Google Scholar]
  • 88. Laakkonen ML, Kautiainen H, Hölttä E, et al. Effects of self‐management groups for people with dementia and their spouses—randomized controlled trial. J Am Geriatr Soc. 2016;64(4):752‐760. [DOI] [PubMed] [Google Scholar]
  • 89. Daykin N, Parry B, Ball K, et al. The role of participatory music making in supporting people with dementia in hospital environments. Dementia (London). 2018;17(6):686‐701. [DOI] [PubMed] [Google Scholar]
  • 90. Sogaard R, Sorensen J, Waldorff FB, et al. Early psychosocial intervention in Alzheimer's disease: cost utility evaluation alongside the Danish Alzheimer's Intervention Study (DAISY). BMJ Open. 2014;4(1):e004105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Joling KJ, Bosmans JE, van Marwijk HW, et al. The cost‐effectiveness of a family meetings intervention to prevent depression and anxiety in family caregivers of patients with dementia: a randomized trial. Trials. 2013;14:305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Woods RT, Bruce E, Edwards RT, et al. REMCARE: reminiscence groups for people with dementia and their family caregivers ‐ effectiveness and cost‐effectiveness pragmatic multicentre randomised trial. Health Technol Assess. 2012;16(48):v‐xv, 1‐116. [DOI] [PubMed] [Google Scholar]
  • 93. Nichols LO, Martindale‐Adams J, Zhu CW, Kaplan EK, Zuber JK, Waters TM. Impact of the REACH II and REACH VA Dementia caregiver interventions on healthcare costs. J Am Geriatr Soc. 2017;65(5):931‐936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Garden G, Green S, Pieniak S, Gladman J. The Bromhead Care Home Service: the impact of a service for care home residents with dementia on hospital admission and dying in preferred place of care. Clin Med (Lond). 2016;16(2):114‐118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Gozalo P, Teno JM, Mitchell SL, et al. End‐of‐life transitions among nursing home residents with cognitive issues. N Engl J Med. 2011;365(13):1212‐1221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96. Volicer L, Hurley AC, Blasi ZV. Characteristics of dementia end‐of‐life care across care settings. Am J Hosp Palliat Care. 2003;20(3):191‐200. [DOI] [PubMed] [Google Scholar]
  • 97. Caplan GA, Meller A, Squires B, Chan S, Willett W. Advance care planning and hospital in the nursing home. Age Ageing. 2006;35(6):581‐585. [DOI] [PubMed] [Google Scholar]
  • 98. Livingston G, Lewis‐Holmes E, Pitfield C, et al. Improving the end‐of‐life for people with dementia living in a care home: an intervention study. Int Psychogeriatr. 2013;25(11):1849‐1858. [DOI] [PubMed] [Google Scholar]
  • 99. Gustafsson M, Sjolander M, Pfister B, Schneede J, Lovheim H. Effects of pharmacists' interventions on inappropriate drug use and drug‐related readmissions in people with dementia‐a secondary analysis of a randomized controlled trial. Pharmacy (Basel). 2018;6(1):827‐835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Gustafsson M, Sjolander M, Pfister B, Jonsson J, Schneede J, Lovheim H. Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial. Eur J Clin Pharmacol. 2017;73(7):827‐835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Bellantonio S, Kenny AM, Fortinsky RH, et al. Efficacy of a geriatrics team intervention for residents in dementia‐specific assisted living facilities: effect on unanticipated transitions. J Am Geriatr Soc. 2008;56(3):523‐528. [DOI] [PubMed] [Google Scholar]
  • 102. Challis D, Clarkson P, Williamson J, et al. The value of specialist clinical assessment of older people prior to entry to care homes. Age Ageing. 2004;33(1):25‐34. [DOI] [PubMed] [Google Scholar]
  • 103. Bosetti A, Gayot C, Preux PM, Tchalla A. Effectiveness of a geriatric emergency medicine unit for the management of neurocognitive disorders in older patients: results of the MUPACog Study. Dement Geriatr Cogn Disord. 2020;49(4):394‐400. [DOI] [PubMed] [Google Scholar]
  • 104. Beauchet O, Fantino B, Allali G, Muir SW, Montero‐Odasso M, Annweiler C. Timed Up and Go test and risk of falls in older adults: a systematic review. J Nutr Health Aging. 2011;15(10):933‐8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105. Catic AG, Mattison ML, Bakaev I, Morgan M, Monti SM, Lipsitz L. ECHO‐AGE: an innovative model of geriatric care for long‐term care residents with dementia and behavioral issues. J Am Med Dir Assoc. 2014;15(12):938‐942. [DOI] [PubMed] [Google Scholar]
  • 106. Lyketsos CG, Roques C, Hovanec L, Jones BN, 3rd . Telemedicine use and the reduction of psychiatric admissions from a long‐term care facility. J Geriatr Psychiatry Neurol. 2001;14(2):76‐79. [DOI] [PubMed] [Google Scholar]
  • 107. De Luca R, Bramanti A, De Cola MC, et al. Tele‐health‐care in the elderly living in nursing home: the first Sicilian multimodal approach. Aging Clin Exp Res. 2016;28:753‐759. [DOI] [PubMed] [Google Scholar]
  • 108. Stenvall M, Berggren M, Lundstrom M, Gustafson Y, Olofsson B. A multidisciplinary intervention program improved the outcome after hip fracture for people with dementia–subgroup analyses of a randomized controlled trial. Arch Gerontol Geriatr. 2012;54(3):e284‐e289. [DOI] [PubMed] [Google Scholar]
  • 109. Burke RE, Xu Y, Ritter AZ, Werner RM. Postacute care outcomes in home health or skilled nursing facilities in patients with a diagnosis of dementia. Health Serv Res. 2022;57(3):497‐504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. Menn P, Holle R, Kunz S, et al. Dementia care in the general practice setting: a cluster randomized trial on the effectiveness and cost impact of three management strategies. Value Health. 2012;15(6):851‐859. [DOI] [PubMed] [Google Scholar]
  • 111. Brodaty H, Aerts L, Harrison F, et al. Antipsychotic deprescription for older adults in long‐term care: the HALT Study. J Am Med Dir Assoc. 2018;19(7):592‐600 e7. [DOI] [PubMed] [Google Scholar]
  • 112. Yeh YC, Liu CL, Peng LN, Lin MH, Chen LK. Potential benefits of reducing medication‐related anticholinergic burden for demented older adults: a prospective cohort study. Geriatr Gerontol Int. 2013;13(3):694‐700. [DOI] [PubMed] [Google Scholar]
  • 113. Tropea J, Nestel D, Johnson C, et al. Evaluation of IMproving Palliative Care Education and Training Using Simulation in Dementia (IMPETUS‐D) a staff simulation training intervention to improve palliative care of people with advanced dementia living in nursing homes: a cluster randomised controlled trial. BMC Geriatr. 2022;22(1):127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Isaac LM, Buggy E, Sharma A, Karberis A, Maddock KM, Weston KM. Enhancing hospital care of patients with cognitive impairment. Int J Health Care Qual Assur. 2018;31(2):173‐186. [DOI] [PubMed] [Google Scholar]
  • 115. Allegri N, Rosi A, Del Signore F, et al. Dementia‐friendly intervention for hospitalized older adults with cognitive impairments: results of the Italian Dementia‐Friendly Hospital Trial (IDENTITA). Aging Ment Health. 2022;26(4):716‐724. [DOI] [PubMed] [Google Scholar]
  • 116. Briggs R, Coary R, Collins R, Coughlan T, O'Neill D, Kennelly SP. Acute hospital care: how much activity is attributable to caring for patients with dementia? QJM. 2016;109(1):41‐44. [DOI] [PubMed] [Google Scholar]
  • 117. Goldberg SE, Bradshaw LE, Kearney FC, et al. Care in specialist medical and mental health unit compared with standard care for older people with cognitive impairment admitted to general hospital: randomised controlled trial (NIHR TEAM trial). BMJ. 2013;347:f4132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118. Young C, Edwards C, Singh I. Impact of hospital design on acutely unwell patients with dementia. Geriatrics (Basel). 2017;2(1):4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119. Knight S, Singh I. Profile of inpatient falls in patients with dementia: a prospective comparative study between 100% single rooms and traditional multibedded wards. J Clin Gerontol Geriatr. 2016;7(3):87‐92. [Google Scholar]
  • 120. Rosler A, Pfeil S, Lessmann H, Hoder J, Befahr A, von Renteln‐Kruse W. Dysphagia in dementia: influence of dementia severity and food texture on the prevalence of aspiration and latency to swallow in hospitalized geriatric patients. J Am Med Dir Assoc. 2015;16(8):697‐701. [DOI] [PubMed] [Google Scholar]
  • 121. Kazui H, Hashimoto M, Nakano Y, et al. Effectiveness of a clinical pathway for the diagnosis and treatment of dementia and for the education of families. Int J Geriatr Psychiatry. 2004;19(9):892‐897. [DOI] [PubMed] [Google Scholar]
  • 122. Villars H, Dupuy C, Soler P, et al. A follow‐up intervention in severely demented patients after discharge from a special Alzheimer acute care unit: impact on early emergency room re‐hospitalization rate. Int J Geriatr Psychiatry. 2013;28(11):1131‐1140. [DOI] [PubMed] [Google Scholar]
  • 123. Agar M, Luckett T, Luscombe G, et al. Effects of facilitated family case conferencing for advanced dementia: a cluster randomised clinical trial. PLoS One. 2017;12(8):e0181020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124. Cassel BJ, Kerr KM, McClish DK, et al. Effect of a home‐based palliative care program on healthcare use and costs. J Am Geriatr Soc. 2016;64(11):2288‐2295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125. Mashlan W, Ralston S, Jones L. Meaningful engagement between secondary school students and older patients in an acute hospital. Nurs Older People. 2020;32(2): e1190. [DOI] [PubMed] [Google Scholar]
  • 126. de Souto Barreto P, Maltais M, Rosendahl E, et al. Exercise effects on falls, fractures, hospitalizations, and mortality in older adults with dementia: an individual‐level patient data meta‐analysis. J Gerontol A Biol Sci Med Sci. 2021;76(9):e203‐e212. [DOI] [PubMed] [Google Scholar]
  • 127. Radbruch L, Payne, SA . White paper on standards and norms for hospice and palliative care in Europe: part 1. Eur J Palliat Care. 2009;16(6):278‐289. [Google Scholar]
  • 128. Sampson EL, Anderson JE, Candy B, et al. Empowering Better End‐of‐Life Dementia Care (EMBED‐Care): a mixed methods protocol to achieve integrated person‐centred care across settings. Int J Geriatr Psychiatry. 2020;35(8):820‐832. [DOI] [PubMed] [Google Scholar]
  • 129. National Institute for Health and Care Excellence . NICE Guideline NG142: End of life care for adults: service delivery. 2019. Accessed February 28, 2026. Available from: https://www.nice.org.uk/guidance/ng142 [PubMed]
  • 130. Nicholas LH, Bynum JP, Iwashyna TJ, Weir DR, Langa KM. Advance directives and nursing home stays associated with less aggressive end‐of‐life care for patients with severe dementia. Health Aff (Millwood). 2014;33(4):667‐674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131. Wendrich‐van Dael A, Bunn F, Lynch J, Pivodic L, Van den Block L, Goodman C. Advance care planning for people living with dementia: an umbrella review of effectiveness and experiences. Int J Nurs Stud. 2020;107:103576. [DOI] [PubMed] [Google Scholar]
  • 132. Gilissen J, Pivodic L, Gastmans C, et al. How to achieve the desired outcomes of advance care planning in nursing homes: a theory of change. BMC Geriatr. 2018;18(1):47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133. Guirguis‐Blake JM, Michael YL, Perdue LA, Coppola EL, Beil TL. Interventions to prevent falls in older adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319(16):1705‐1716. [DOI] [PubMed] [Google Scholar]
  • 134. Miller SC, Lima JC, Intrator O, Martin E, Bull J, Hanson LC. Palliative care consultations in nursing homes and reductions in acute care use and potentially burdensome end‐of‐life transitions. J Am Geriatr Soc. 2016;64(11):2280‐2287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135. Farinha‐Costa B, Reis‐Pina P. Home hospitalization in palliative care for advanced cancer and dementia: a systematic review. J Pain Symptom Manage. 2025;69(3):289‐303. [DOI] [PubMed] [Google Scholar]
  • 136. Van der Steen JT, Radbruch L, Hertogh CM, et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med. 2014;28(3):197‐209. [DOI] [PubMed] [Google Scholar]
  • 137. Graham FA, Kelly L, Burmeister EA, et al. A hospital‐based special care unit for dementia decreased hospital readmission rates for behaviour while reducing rates of falls and occupational violence across medical wards. Age Ageing. 2025;54(4):afaf096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138. Yang Y, Huh K, Kwak YT. The influence of a specialized dementia ward on the treatment of Alzheimer's disease patients. J Pers Med. 2025;15(3):82. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

ALZ-22-e71323-s001.docx (78.8KB, docx)

Supporting Information

ALZ-22-e71323-s002.pdf (5.4MB, pdf)

Articles from Alzheimer's & Dementia are provided here courtesy of Wiley

RESOURCES